BioPortUSA has once again been asked to participate as a presenter at this year's BioTech Venture Leaders meeting in Boston on June 13th. This year's focus will be on what it takes to successfully commercialize your technology in the United States. We will also have two other subject matter experts discuss the implications of the Inflation Reduction Act on the Biotech and Pharmaceutical community as well as a presentation on the Drug Supply Chain Security Act. Understanding both of these new pieces of legislation will be critical if a company will be successful in commercializing their products.
Jordi Montserrat who heads up the VentureLab has stated that “having Mark and his team provide an overview of the U.S. Healthcare system has been invaluable for our Start-ups.”
The Venture Leaders are members of the Swiss National Startup Team. They envision themselves as global players and want to take the first step to their global expansion. The Venture Leaders’ startup development program is specifically structured to help them achieve these goals. This intense journey offers 10 selected entrepreneurs an accelerated learning curve and a solid network through their exchanges with their peers in the team, as well as market exposure, feedback from investors and experts, and hands-on business development.